This article has Open Peer Review reports available.
Guanylate-binding protein-1 is a potential new therapeutic target for triple-negative breast cancer
- Melissa Quintero†1,
- Douglas Adamoski†1, 3,
- Larissa Menezes dos Reis†1, 3,
- Carolline Fernanda Rodrigues Ascenção1, 3,
- Krishina Ratna Sousa de Oliveira1, 3,
- Kaliandra de Almeida Gonçalves1,
- Marília Meira Dias1,
- Marcelo Falsarella Carazzolle2 and
- Sandra Martha Gomes Dias1Email author
© The Author(s). 2017
Received: 12 January 2017
Accepted: 30 October 2017
Published: 7 November 2017
Open Peer Review reports
Pre-publication versions of this article and author comments to reviewers are available by contacting email@example.com.
|12 Jan 2017||Submitted||Original manuscript|
|4 Feb 2017||Reviewed||Reviewer Report - WEI WEI|
|27 Feb 2017||Reviewed||Reviewer Report - Yong Wang|
|12 May 2017||Author responded||Author comments - Melissa Quintero|
|Resubmission - Version 2|
|12 May 2017||Submitted||Manuscript version 2|
|12 Aug 2017||Author responded||Author comments - Melissa Quintero|
|Resubmission - Version 3|
|12 Aug 2017||Submitted||Manuscript version 3|
|4 Oct 2017||Author responded||Author comments - Melissa Quintero|
|Resubmission - Version 4|
|4 Oct 2017||Submitted||Manuscript version 4|
|30 Oct 2017||Editorially accepted|
|7 Nov 2017||Article published||10.1186/s12885-017-3726-2|
How does Open Peer Review work?
Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting firstname.lastname@example.org. All previous versions of the manuscript and all author responses to the reviewers are also available.
You can find further information about the peer review system here.